Navigation Links
Merck Serono Named as a Top Employer by Science Magazine
Date:10/9/2008

GENEVA, Switzerland, October 10 /PRNewswire-FirstCall/ --

- Ranked Number 7 out of top 20 Employers Across Life Sciences Industry

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has been named by Science magazine as a top employer in the biotechnology and pharmaceutical industries, ranking number 7 out of the top 20 employers across the life sciences.

"We are honored that the scientific community has recognized Merck Serono as a leading place to work," said Bernhard Kirschbaum, Executive Vice President, Research, Merck Serono. "Our success as a leader within the biopharmaceutical industry is a direct result of the hard work, passion and dedication of our employees. We are committed to creating an environment for our scientists that fosters growth, professional development and a place where intellectually curious people can thrive and grow with a common goal of finding new treatments for unmet medical needs."

This is the second time Merck Serono has been placed on Science magazine's Top Employer survey; previously the organization ranked number 17.

The survey sought to determine which biotechnology and pharmaceutical companies were most admired by people who work in the field, and why. Survey respondents also rated the companies on 23 different attributes, which included Corporate Image, Financial Prowess, Leadership and Direction, Work/Culture Environment, Location and Academic and Intellectual Challenge. The methodology used for the survey included email invitations to AAAS members, Science Careers registrants, and Science website visitors.

The ranking is a result of a survey conducted by Science magazine, along with the American Association for the Advancement of Science (AAAS), and commissioned by Senn-Delaney Culture Diagnostics and Measurement to conduct a web-based survey aimed at determining the companies in the biotechnology and pharmaceutical industries with the best reputa
'/>"/>

SOURCE Merck Serono
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc.
2. Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast
3. BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance
4. New Therapy by Merck is Positioned to Earn Gold-Standard Status by 2011 in the Treatment of Chemotherapy-Induced Nausea and Vomiting
5. Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Sciences Inaugural Conference
6. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
7. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
8. Merck Will Obtain Blockbuster Antidiabetic Drug Sales in Type 2 Diabetes Market by 2011
9. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
10. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
11. EMD Serono Named as a Top Employer by Science Magazine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...wswire-FirstCall/ - Microbix Biosystems Inc. (the ...e Form 52-109F1 Certification of Annual Filings of...ames Long, the Chief Financial Officer (the "Offic...ection with the annual audited financial statement... Company initially filed the annual financial stat...
(Date:11/6/2009)...v. 6 ,, 3Q09 Corpo...tenza(TM) E.U. Marketing Authorization to Astellas... commercial readiness activities Expanded managem...keting; and Director, Commercial Operations Appoi...Audit Committee chairman , Upcoming 2009 Mi...
(Date:11/5/2009)... hybrid . . . , Fuel economy ratings for the n...he www.fueleconomy.gov web site, which Oak Ridge...he U.S. Department of Energy and the U.S. Environm...es on the best fuel economy list are hybrid electr...way). "This list proves that hybrids have gone mai...
(Date:11/5/2009)...., Nov. 5 ThermoGenesis ...vative products for processing and storing adult s...arter of fiscal 2010. ,, For the quarter ended ...of $5.2 million, a 15 percent increase over revenu.... The Company said the key contributors to the gro...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...Increasing Global Need for Genzyme Products, CAMB...NZ ) today broke ground on a significant expansion... Landing in Boston. The $150,million project is fo...nctions, and will allow for the creation of 90 job...ng Massachusetts Governor,Deval L. Patrick, Boston...
...Effort to Target Drug-Resistant Gram Negative ..., Sept. 18 GlaxoSmithKline (NYSE:,GSK) today anno...ense,Threat Reduction Agency (DTRA) of the U.S. De... a new class of antibacterials targeting both Gram...e hospital pathogens. The,agreement awards GSK up ...
...8 BioReliance Corporation, a,leading contract ser...harmaceutical industries, announced today the laun...ystem that enables customers to submit,test articl...s from any,location worldwide. In real-time, BioRe...and past studies, keep informed of expected comple...
Other Biology Technology:Genzyme Begins Major Expansion of Boston Manufacturing Facility 2Genzyme Begins Major Expansion of Boston Manufacturing Facility 3Genzyme Begins Major Expansion of Boston Manufacturing Facility 4Genzyme Begins Major Expansion of Boston Manufacturing Facility 5GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program 2GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program 3BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests 2
(Date:11/6/2009)...RNewswire/ -- Auburn Hills, MI-based Law Enforceme...ing its locker system and patent-pending Biometric...rtment of Health and Human Services, National Inst... locker system will support the NIH,s entire polic...ion,s medical research agency. The project is exp...
(Date:11/4/2009)... scientists are reluctant to officially endorse gr...ntinues to grow about its protective effects, incl...Prevention Research , a journal of the American As... reduction in oral cancer. , Vassiliki Papadimi...artment of Thoracic/Head and Neck Medical Oncology...
(Date:11/4/2009)...ry that deciphered the DNA codes, or genomes, of t...has joined The Genome 10K Project, an internationa...sequences on 10,000 species of animals for conduct...can not be achieved. , Participating in The Geno...the Nov. 5, 2009 issue of the Journal of Heredity...
Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Singapore scientists join international study of 10,000 vertebrates' genomes 2OB10 and Memorial Hermann to Co host June 17 Audio Conference on e Invoicing and PCard Spend 48841 1OB10 and Memorial Hermann to Co host June 17 Audio Conference on e Invoicing and PCard Spend 48841 2EnovateIT Announces New Enovate Medical Cart Series 48835 1EnovateIT Announces New Enovate Medical Cart Series 48835 2EnovateIT Announces New Enovate Medical Cart Series 48835 3EnovateIT Announces New Enovate Medical Cart Series 48835 4EnovateIT Announces New Enovate Medical Cart Series 48835 5EnovateIT Announces New Enovate Medical Cart Series 48835 6Colleges communities combat off campus student drinking 48832 1Colleges communities combat off campus student drinking 48832 2
...n his computer screen. The dot ?which represents a...rphing into a mass with finger-like projections th...professor of cancer biology envisions a future whe...redict a tumor,s clinical progression and formulat... years, he has headed a major effort to develop th...
... sensitive "handles" for biological molecules bein... can heat up fast--by tens of degrees in just a fe...ules or help study them, according to scientists a...e of Standards and Technology (NIST) and Universit...udy nanoscale and even picoscale mechanics by usin...
...low down the progress of the fatal brain disease s...rchers from the Universities of Munich and Bonn to...titute in Martinsried. To do this they used an eff...nd Andrew Fire, for which they were awarded this y...nt of the cattle disease BSE and the human equival...
Other Biology News:Math model predicts cancer behavior 2Math model predicts cancer behavior 3Math model predicts cancer behavior 4New approach to BSE successful in lab 2New approach to BSE successful in lab 3
...n Blot Strong Antibody Stripping Solution is effec...that have been developed with chemiluminescence or...ecommended for stripping colorimetric substrates (...sible to effectively remove substrates that precip...
Hybrid Hunter Yeast Two-Hybrid System from Invitrogen
Helios Gene Gun Low-Pressure System, 100-120 V from Bio-Rad
Anti-Transglutaminase II Monoclonal Antibody, Unconjugated, Clone CUB7402 from Diagnostic BioSystems
Biology Products: